Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID is more common in those with severe initial infections, but not linked to blood group.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

COVID-19 can cause temporary hair loss.

COVID-19 can cause skin problems in children.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 may cause temporary hair loss due to the body's immune response.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Intravenous delivery of autologous activated platelet-rich plasma is safe.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

New understanding and treatments for hair loss are improving, but more research is needed.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.